MeSH Browser

MeSH Heading: Purpura, Thrombocytopenic, Idiopathic
Tree Number(s): C15.378.100.802.687.600; C15.378.140.855.925.750.600; C15.378.463.740; C20.111.759; C20.841.600; C23.550.414.950.687.600; C23.888.885.687.687.600
Unique ID: D016553
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D016553
Scope Note: Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms.
Entry Term(s): Autoimmune Thrombocytopenia; Autoimmune Thrombocytopenic Purpura; Idiopathic Thrombocytopenic Purpura; Immune Thrombocytopenia; Immune Thrombocytopenic Purpura; Purpura, Thrombocytopenic, Autoimmune; Thrombocytopenic Purpura, Autoimmune; Werlhof Disease; Werlhof's Disease
NLM Classification #: WH 322
Previous Indexing: Purpura, Thrombocytopenic (1966-1991)
Public MeSH Note: 1992; for WERLHOF'S DISEASE see PURPURA, THROMBOCYTOPENIC 1975-1991
History Note: 1992; for WERLHOF'S DISEASE use PURPURA, THROMBOCYTOPENIC 1975-1991
Date Established: 1992/01/01
Date of Entry: 1991/04/29
Revision Date: 2012/07/03

Allowable Qualifiers: blood (BL)

cerebrospinal fluid (CF)

chemically induced (CI)

classification (CL)

complications (CO)

congenital (CN)

diagnosis (DI)

diagnostic imaging (DG)

diet therapy (DH)

drug therapy (DT)

economics (EC)

embryology (EM)

enzymology (EN)

epidemiology (EP)

ethnology (EH)

etiology (ET)

genetics (GE)

history (HI)

immunology (IM)

metabolism (ME)

microbiology (MI)

mortality (MO)

nursing (NU)

parasitology (PS)

pathology (PA)

physiopathology (PP)

prevention & control (PC)

psychology (PX)

radiotherapy (RT)

rehabilitation (RH)

surgery (SU)

therapy (TH)

urine (UR)

veterinary (VE)

virology (VI)

Hemic and Lymphatic Diseases [C15]
- Hematologic Diseases [C15.378]
  - Blood Coagulation Disorders [C15.378.100]
    - Purpura [C15.378.100.802]
      - Purpura, Thrombocytopenic [C15.378.100.802.687]
        
        Purpura, Thrombocytopenic, Idiopathic [C15.378.100.802.687.600]
        
        Purpura, Thrombotic Thrombocytopenic [C15.378.100.802.687.680]

Hemic and Lymphatic Diseases [C15]
- Hematologic Diseases [C15.378]
  - Blood Platelet Disorders [C15.378.140]
    - Thrombocytopenia [C15.378.140.855]
      - Thrombotic Microangiopathies [C15.378.140.855.925]
        
        Purpura, Thrombocytopenic [C15.378.140.855.925.750]
        
        Purpura, Thrombocytopenic, Idiopathic [C15.378.140.855.925.750.600]
        
        Purpura, Thrombotic Thrombocytopenic [C15.378.140.855.925.750.680]

Hemic and Lymphatic Diseases [C15]
- Hematologic Diseases [C15.378]
  - Hemorrhagic Disorders [C15.378.463]

Immune System Diseases [C20]
- Autoimmune Diseases [C20.111]

Immune System Diseases [C20]
- Purpura, Thrombocytopenic [C20.841]
  - Purpura, Thrombocytopenic, Idiopathic [C20.841.600]

Pathological Conditions, Signs and Symptoms [C23]
- Pathologic Processes [C23.550]
  - Hemorrhage [C23.550.414]
    - Purpura [C23.550.414.950]
      - Purpura, Thrombocytopenic [C23.550.414.950.687]
        
        Purpura, Thrombocytopenic, Idiopathic [C23.550.414.950.687.600]
        
        Purpura, Thrombotic Thrombocytopenic [C23.550.414.950.687.680]

Pathological Conditions, Signs and Symptoms [C23]
- Signs and Symptoms [C23.888]
  - Skin Manifestations [C23.888.885]
    - Purpura [C23.888.885.687]
      - Purpura, Thrombocytopenic [C23.888.885.687.687]
        
        Purpura, Thrombocytopenic, Idiopathic [C23.888.885.687.687.600]
        
        Purpura, Thrombotic Thrombocytopenic [C23.888.885.687.687.680]

Purpura, Thrombocytopenic, Idiopathic Preferred

Concept UI: M0025253
Scope Note: Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms.
Terms: Purpura, Thrombocytopenic, Idiopathic Preferred Term
Term UI T049523
Date01/01/1999
LexicalTag NON
ThesaurusID NLM (1992); Idiopathic Thrombocytopenic Purpura
Term UI T049522
Date09/19/1990
LexicalTag NON
ThesaurusID; Immune Thrombocytopenic Purpura
Term UI T811945
Date11/15/2011
LexicalTag NON
ThesaurusID OMIM (2013); Immune Thrombocytopenia
Term UI T848933
Date09/06/2013
LexicalTag NON
ThesaurusID NLM (2015); Thrombocytopenic Purpura, Autoimmune
Term UI T811946
Date11/15/2011
LexicalTag NON
ThesaurusID OMIM (2013); Werlhof Disease
Term UI T049518
Date10/16/1990
LexicalTag EPO
ThesaurusID NLM (1992); Werlhof's Disease
Term UI T049519
Date10/16/1990
LexicalTag EPO
ThesaurusID NLM (1992); Autoimmune Thrombocytopenia
Term UI T049524
Date09/19/1990
LexicalTag NON
ThesaurusID NLM (1992); Autoimmune Thrombocytopenic Purpura
Term UI T049520
Date09/19/1990
LexicalTag NON
ThesaurusID; Purpura, Thrombocytopenic, Autoimmune
Term UI T049521
Date09/19/1990
LexicalTag NON
ThesaurusID NLM (1992)

Purpura, Thrombocytopenic, Idiopathic MeSH Descriptor Data 2023